Timothy Cahill

Timothy Cahill

Partner Of Counsel


  • Health Care Industry

WSG Practice Industries


Dinsmore & Shohl LLP
Ohio, U.S.A.


Tim is an attorney with more than two decades of experience in health care-related fields. He has worked as in-house counsel and external counsel for non-profit and commercial health care organizations, health systems, hospitals, physicians and physician groups, joint ventures, and other corporate clients. Most recently, Tim served in the role of general counsel of a regional health system, working closely with the executive team and board to further the organization’s strategic mission and significantly improve operating revenues.

In his practice, Tim has addressed a wide range of issues related to health care regulatory compliance, fair market value, internal investigations, risk management, medical staff and licensure issues, research, conflicts of interest, managed care contracting, corporate governance, mergers and acquisitions, joint ventures, and other corporate transactions that have led to significant growth for his corporate clients.  He has negotiated deals with global pharma, medical device, and health care corporations, as well as numerous regional and national health care nonprofits. Given his previous in-house roles, he has an intimate knowledge of hospital and physician practice operations, finance, and reimbursement issues.

Tim has spent a good portion of his legal career on life sciences regulatory and transactional issues. In this capacity, Tim has worked on research compliance matters related to IRBs and human subject protections, informed consent, subject injury, conflict of interest, HIPAA privacy and security, and quality outcome studies. He also has extensive experience with transactional issues in the life sciences area, including contracting matters related to clinical trials, investigator-initiated arrangements, material transfers, tech transfer, NIH grants, federal contracts, consulting, speaker, and scientific advisory boards.

Bar Admissions



  • University of Cincinnati College of Law (J.D., 2003)
  • The Ohio State University (B.S., 1996)
    • Physical Therapy
Areas of Practice

Health Care Industry | Life Sciences Corporate & Transactional | Life Sciences Corporate Compliance & Ethics | Life Sciences FCA Defense | Life Sciences FDA Research, Enforcement & Litigation | Life Sciences Industry | Life Sciences Intellectual Property | Life Sciences Internal Investigations | Life Sciences Litigation | Life Sciences Privacy & Cybersecurity | Life Sciences Regulatory Counseling & Compliance | Mergers & Acquisitions

Professional Career

Significant Accomplishments

  • Ohio Rising Star (2009)

Professional Associations

  • Society of Ohio Health Care Attorneys
    • President (2020-2021)
    • Vice president (2018 - 2019)
    • Secretary (2016 - 2017)
    • Board member (2013 - 2015)
  • American Health Lawyers Association
  • American Health Lawyers Association, Children’s Hospital Affinity Group, vice chair of Strategic Activities (2014 - 2015)
  • Leadership Columbus (2013)
  • Columbus Bar Association, chair of the Health Law Committee (2007 - 2009)


Health Care Noncompetes Are Under Attack
Dinsmore & Shohl LLP, July 2021

On July 9, 2021, President Joe Biden signed a wide-ranging executive order entitled “Promoting Competition in the American Economy.” One key element of the executive order is to address noncompete covenants that the White House characterized as stifling competition between companies. Section 5(g) encouraged the FTC to draft rules which seek to “curtail the unfair use of non-compete clauses and other clauses or agreements that may unfairly limit worker mobility...

FDA Announces Revocation of Policy on Information Related to New Drug Applications
Dinsmore & Shohl LLP, May 2021

On April 30, 2021, the U.S. Food and Drug Administration (FDA) announced it was revoking a policy related to new drug applications (NDAs) and abbreviated new drug applications (ANDAs). The FDA stated that the previous policy announced by the Department of Health and Human Services (HHS) on Jan. 15, 2021, was being rescinded because the new policy would have required the FDA to publish redundant information about new applications of NDAs and ANDAs...

COVID-19 Waivers Ending for Skilled Nursing Facilities
Dinsmore & Shohl LLP, April 2021

On April 8, 2021, the Centers for Medicare and Medicaid Services (CMS) announced that some of the blanket waivers implemented during COVID-19 will expire on May 10, 2021.[1] The following waivers will expire: The emergency blanket waivers related to notification of resident room or roommate changes, and transfer and discharge notification requirements...